{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:01:54Z","timestamp":1783980114531,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s40744-023-00570-0","type":"journal-article","created":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T19:49:33Z","timestamp":1687549773000},"page":"1073-1087","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation Analysis"],"prefix":"10.1007","volume":"10","author":[{"given":"Lars Erik","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Navarro-Comp\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Magrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Bushmakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Cappelleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Yndestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaseyi","family":"Dina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,23]]},"reference":[{"issue":"F1000 Faculty R","key":"570_CR1","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.12688\/f1000research.14956.1","volume":"7","author":"L Garcia-Montoya","year":"2018","unstructured":"Garcia-Montoya L, Gul H, Emery P. Recent advances in ankylosing spondylitis: understanding the disease and management. F1000Res. 2018;7(F1000 Faculty Rev):1512.","journal-title":"F1000Res"},{"key":"570_CR2","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Ramiro S, Landew\u00e9 R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76:978\u201391.","journal-title":"Ann Rheum Dis"},{"key":"570_CR3","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1136\/annrheumdis-2021-221035","volume":"80","author":"V Navarro-Comp\u00e1n","year":"2021","unstructured":"Navarro-Comp\u00e1n V, Sepriano A, El-Zorkany B, van der Heijde D. Axial spondyloarthritis. Ann Rheum Dis. 2021;80:1511\u201321.","journal-title":"Ann Rheum Dis"},{"key":"570_CR4","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1016\/j.mayocp.2020.02.007","volume":"95","author":"MN Magrey","year":"2020","unstructured":"Magrey MN, Danve AS, Ermann J, Walsh JA. Recognizing axial spondyloarthritis: a guide for primary care. Mayo Clin Proc. 2020;95:2499\u2013508.","journal-title":"Mayo Clin Proc"},{"key":"570_CR5","doi-asserted-by":"publisher","first-page":"3027280","DOI":"10.1155\/2019\/3027280","volume":"2019","author":"D Connolly","year":"2019","unstructured":"Connolly D, Fitzpatrick C, O\u2019Shea F. Disease activity, occupational participation, and quality of life for individuals with and without severe fatigue in ankylosing spondylitis. Occup Ther Int. 2019;2019:3027280.","journal-title":"Occup Ther Int"},{"key":"570_CR6","doi-asserted-by":"publisher","first-page":"vi1","DOI":"10.1093\/rheumatology\/key079","volume":"57","author":"J Braun","year":"2018","unstructured":"Braun J. Axial spondyloarthritis including ankylosing spondylitis. Rheumatology (Oxford). 2018;57:vi1\u20133.","journal-title":"Rheumatology (Oxford)"},{"key":"570_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10067-014-2682-3","volume":"34","author":"EE Schneeberger","year":"2015","unstructured":"Schneeberger EE, Marengo MF, Dal Pra F, Maldonado Cocco JA, Citera G. Fatigue assessment and its impact in the quality of life of patients with ankylosing spondylitis. Clin Rheumatol. 2015;34:497\u2013501.","journal-title":"Clin Rheumatol"},{"key":"570_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00296-007-0313-x","volume":"27","author":"Y Turan","year":"2007","unstructured":"Turan Y, Duru\u00f6z MT, Bal S, Guvenc A, Cerrahoglu L, Gurgan A. Assessment of fatigue in patients with ankylosing spondylitis. Rheumatol Int. 2007;27:847\u201352.","journal-title":"Rheumatol Int"},{"key":"570_CR9","doi-asserted-by":"publisher","first-page":"e446","DOI":"10.1097\/RHU.0000000000001544","volume":"27","author":"V Strand","year":"2021","unstructured":"Strand V, Deodhar A, Alten R, et al. Pain and fatigue in patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors: multinational real-world findings. J Clin Rheumatol. 2021;27:e446\u201355.","journal-title":"J Clin Rheumatol"},{"key":"570_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237117","volume":"15","author":"BA Esbensen","year":"2020","unstructured":"Esbensen BA, Stallknecht SE, Madsen ME, Hagelund L, Pilgaard T. Correlations of fatigue in Danish patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis. PLoS ONE. 2020;15: e0237117.","journal-title":"PLoS ONE"},{"key":"570_CR11","first-page":"1003","volume":"26","author":"D van der Heijde","year":"1999","unstructured":"van der Heijde D, van der Linden S, Dougados M, Bellamy N, Russell AS, Edmonds J. Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments. J Rheumatol. 1999;26:1003\u20135.","journal-title":"J Rheumatol"},{"key":"570_CR12","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.semarthrit.2021.07.021","volume":"51","author":"V Navarro-Comp\u00e1n","year":"2021","unstructured":"Navarro-Comp\u00e1n V, Boel A, Boonen A, et al. The ASAS-OMERACT core domain set for axial spondyloarthritis. Semin Arthritis Rheum. 2021;51:1342\u20139.","journal-title":"Semin Arthritis Rheum"},{"key":"570_CR13","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1136\/ard.2010.145995","volume":"70","author":"D Poddubnyy","year":"2011","unstructured":"Poddubnyy D, Rudwaleit M, Haibel H, et al. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis. 2011;70:1369\u201374.","journal-title":"Ann Rheum Dis"},{"key":"570_CR14","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2016-210322","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Deodhar A, Wei JC, et al. Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study. Ann Rheum Dis. 2017;76:1340\u20137.","journal-title":"Ann Rheum Dis"},{"key":"570_CR15","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1136\/annrheumdis-2020-219601","volume":"80","author":"A Deodhar","year":"2021","unstructured":"Deodhar A, Sliwinska-Stanczyk P, Xu H, et al. Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study. Ann Rheum Dis. 2021;80:1004\u201313.","journal-title":"Ann Rheum Dis"},{"key":"570_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002253","volume":"8","author":"V Navarro-Comp\u00e1n","year":"2022","unstructured":"Navarro-Comp\u00e1n V, Wei JCC, Van den Bosch F, et al. Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial. RMD Open. 2022;8: e002253.","journal-title":"RMD Open"},{"key":"570_CR17","doi-asserted-by":"publisher","DOI":"10.1201\/b16139","volume-title":"Patient-reported outcomes: measurement, implementation and interpretation","author":"JC Cappelleri","year":"2013","unstructured":"Cappelleri JC, Zou KH, Bushmakin AG, Alvir JMJ, Alemayehu D, Symonds T. Patient-reported outcomes: measurement, implementation and interpretation. Boca Raton: Chapman & Hall\/CRC; 2013."},{"key":"570_CR18","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.3389\/fpsyg.2017.01984","volume":"8","author":"R Agler","year":"2017","unstructured":"Agler R, De Boeck P. On the interpretation and use of mediation: multiple perspectives on mediation analysis. Front Psychol. 2017;8:1984.","journal-title":"Front Psychol"},{"key":"570_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1513\/AnnalsATS.201808-564PS","volume":"16","author":"DJ Lederer","year":"2019","unstructured":"Lederer DJ, Bell SC, Branson RD, et al. Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals. Ann Am Thorac Soc. 2019;16:22\u20138.","journal-title":"Ann Am Thorac Soc"},{"key":"570_CR20","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1213\/ANE.0b013e3182a44cb9","volume":"117","author":"EJ Mascha","year":"2013","unstructured":"Mascha EJ, Dalton JE, Kurz A, Saager L. Understanding the mechanism: mediation analysis in randomized and nonrandomized studies. Anesth Analg. 2013;117:980\u201394.","journal-title":"Anesth Analg"},{"key":"570_CR21","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.3390\/jcm10184081","volume":"10","author":"PC Taylor","year":"2021","unstructured":"Taylor PC, Bushmakin AG, Cappelleri JC, et al. Itch as major mediator of effect of tofacitinib on health-related quality of life in psoriatic arthritis: a mediation analysis. J Clin Med. 2021;10:4081.","journal-title":"J Clin Med"},{"issue":"Suppl 2","key":"570_CR22","first-page":"924","volume":"78","author":"P Taylor","year":"2019","unstructured":"Taylor P, Mease P, Bushmakin A, et al. Understanding mediators of pain reduction in psoriatic arthritis patients treated with tofacitinib: role of inflammation. Ann Rheum Dis. 2019;78(Suppl 2):924\u20135 (abstract FRI0462).","journal-title":"Ann Rheum Dis"},{"key":"570_CR23","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Integrated addendum to ICH E6(R1): guideline for good clinical practice E6(R2) 2016 [updated November 9, 2016. Available from: https:\/\/database.ich.org\/sites\/default\/files\/E6_R2_Addendum.pdf]."},{"key":"570_CR24","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134.","journal-title":"JAMA"},{"issue":"Suppl 11","key":"570_CR25","doi-asserted-by":"publisher","first-page":"S263","DOI":"10.1002\/acr.20579","volume":"63","author":"S Hewlett","year":"2011","unstructured":"Hewlett S, Dures E, Almeida C. Measures of fatigue: Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS) for severity, effect, and coping, Chalder Fatigue Questionnaire (CFQ), Checklist Individual Strength (CIS20R and CIS8R), Fatigue Severity Scale (FSS), Functional Assessment Chronic Illness Therapy (Fatigue) (FACIT-F), Multi-Dimensional Assessment of Fatigue (MAF), Multi-Dimensional Fatigue Inventory (MFI), Pediatric Quality Of Life (PedsQL) Multi-Dimensional Fatigue Scale, Profile of Fatigue (ProF), Short Form 36 Vitality Subscale (SF-36 VT), and Visual Analog Scales (VAS). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S263\u201386.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"570_CR26","first-page":"811","volume":"32","author":"D Cella","year":"2005","unstructured":"Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol. 2005;32:811\u20139.","journal-title":"J Rheumatol"},{"issue":"Suppl 11","key":"570_CR27","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1002\/acr.20575","volume":"63","author":"J Zochling","year":"2011","unstructured":"Zochling J. Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S47\u201358.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"570_CR28","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21:2286\u201391.","journal-title":"J Rheumatol"},{"key":"570_CR29","doi-asserted-by":"publisher","first-page":"rky017","DOI":"10.1093\/rap\/rky017","volume":"2","author":"NA Pearson","year":"2018","unstructured":"Pearson NA, Packham JC, Tutton E, Parsons H, Haywood KL. Assessing fatigue in adults with axial spondyloarthritis: a systematic review of the quality and acceptability of patient-reported outcome measures. Rheumatol Adv Pract. 2018;2:rky017.","journal-title":"Rheumatol Adv Pract"},{"key":"570_CR30","doi-asserted-by":"publisher","first-page":"1759720X2093427","DOI":"10.1177\/1759720X20934277","volume":"12","author":"M Lorenzin","year":"2020","unstructured":"Lorenzin M, Ometto F, Ortolan A, et al. An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision. Ther Adv Musculoskelet Dis. 2020;12:1759720X20934277.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"570_CR31","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3899\/jrheum.181412","volume":"47","author":"M Skougaard","year":"2020","unstructured":"Skougaard M, J\u00f8rgensen TS, Rifbjerg-Madsen S, et al. Relationship between fatigue and inflammation, disease duration, and chronic pain in psoriatic arthritis: an observational DANBIO registry study. J Rheumatol. 2020;47:548\u201352.","journal-title":"J Rheumatol"},{"key":"570_CR32","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s10067-018-4190-3","volume":"37","author":"A Nie","year":"2018","unstructured":"Nie A, Wang C, Song Y, Xie X, Yang H, Chen H. Prevalence and factors associated with disturbed sleep in outpatients with ankylosing spondylitis. Clin Rheumatol. 2018;37:2161\u20138.","journal-title":"Clin Rheumatol"},{"key":"570_CR33","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10067-018-3984-7","volume":"37","author":"A Wadeley","year":"2018","unstructured":"Wadeley A, Clarke E, Leverment S, Sengupta R. Sleep in ankylosing spondylitis and non-radiographic axial spondyloarthritis: associations with disease activity, gender and mood. Clin Rheumatol. 2018;37:1045\u201352.","journal-title":"Clin Rheumatol"},{"key":"570_CR34","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3899\/jrheum.150832","volume":"43","author":"C L\u00f3pez-Medina","year":"2016","unstructured":"L\u00f3pez-Medina C, Schiotis RE, Font-Ugalde P, et al. Assessment of fatigue in spondyloarthritis and its association with disease activity. J Rheumatol. 2016;43:751\u20137.","journal-title":"J Rheumatol"},{"key":"570_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2474-3-18","volume":"3","author":"P Sarzi-Puttini","year":"2002","unstructured":"Sarzi-Puttini P, Fiorini T, Panni B, Turiel M, Cazzola M, Atzeni F. Correlation of the score for subjective pain with physical disability, clinical and radiographic scores in recent onset rheumatoid arthritis. BMC Musculoskelet Disord. 2002;3:18.","journal-title":"BMC Musculoskelet Disord"},{"key":"570_CR36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.apmr.2017.07.015","volume":"99","author":"V P\u00e9courneau","year":"2018","unstructured":"P\u00e9courneau V, Degbo\u00e9 Y, Barnetche T, Cantagrel A, Constantin A, Ruyssen-Witrand A. Effectiveness of exercise programs in ankylosing spondylitis: a meta-analysis of randomized controlled trials. Arch Phys Med Rehabil. 2018;99:383-9.e1.","journal-title":"Arch Phys Med Rehabil"},{"key":"570_CR37","doi-asserted-by":"publisher","first-page":"R215","DOI":"10.1186\/ar4054","volume":"14","author":"Y Li","year":"2012","unstructured":"Li Y, Zhang S, Zhu J, Du X, Huang F. Sleep disturbances are associated with increased pain, disease activity, depression, and anxiety in ankylosing spondylitis: a case-control study. Arthritis Res Ther. 2012;14:R215.","journal-title":"Arthritis Res Ther"},{"key":"570_CR38","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1177\/0300060513488501","volume":"41","author":"M Hammoudeh","year":"2013","unstructured":"Hammoudeh M, Zack DJ, Li W, Stewart VM, Koenig AS. Associations between inflammation, nocturnal back pain and fatigue in ankylosing spondylitis and improvements with etanercept therapy. J Int Med Res. 2013;41:1150\u20139.","journal-title":"J Int Med Res"},{"key":"570_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/030097400447561","volume":"29","author":"S Hultgren","year":"2000","unstructured":"Hultgren S, Broman JE, Gudbj\u00f6rnsson B, Hetta J, Lindqvist U. Sleep disturbances in outpatients with ankylosing spondylitisa questionnaire study with gender implications. Scand J Rheumatol. 2000;29:365\u20139.","journal-title":"Scand J Rheumatol"},{"key":"570_CR40","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/acr.20233","volume":"62","author":"A Deodhar","year":"2010","unstructured":"Deodhar A, Braun J, Inman RD, et al. Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: results from a randomized, placebo-controlled trial. Arthritis Care Res (Hoboken). 2010;62:1266\u201371.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"570_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jns.2009.08.013","volume":"289","author":"P Martinez-Martin","year":"2010","unstructured":"Martinez-Martin P. Composite rating scales. J Neurol Sci. 2010;289:7\u201311.","journal-title":"J Neurol Sci"},{"key":"570_CR42","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0025-6196(11)62218-0","volume":"77","author":"JA Sloan","year":"2002","unstructured":"Sloan JA, Aaronson N, Cappelleri JC, Fairclough DL, Varricchio C. Assessing the clinical significance of single items relative to summated scores. Mayo Clin Proc. 2002;77:479\u201387.","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 1","key":"570_CR43","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/annrheumdis-2021-eular.62","volume":"80","author":"D Cella","year":"2021","unstructured":"Cella D, Lenderking W, Chongpinitchai P, et al. Psychometric evaluation of Functional Assessment of Chronic Illness Therapy-Fatigue in patients with active ankylosing spondylitis [abstract]. Ann Rheum Dis. 2021;80(Suppl 1):146.","journal-title":"Ann Rheum Dis"},{"key":"570_CR44","first-page":"516","volume":"32","author":"H Dagfinrud","year":"2005","unstructured":"Dagfinrud H, Kjeken I, Mowinckel P, Hagen KB, Kvien TK. Impact of functional impairment in ankylosing spondylitis: impairment, activity limitation, and participation restrictions. J Rheumatol. 2005;32:516\u201323.","journal-title":"J Rheumatol"},{"key":"570_CR45","first-page":"980","volume":"26","author":"A Spoorenberg","year":"1999","unstructured":"Spoorenberg A, van der Heijde D, de Klerk E, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol. 1999;26:980\u20134.","journal-title":"J Rheumatol"},{"key":"570_CR46","doi-asserted-by":"publisher","first-page":"iii8","DOI":"10.1136\/ard.61.suppl_3.iii8","volume":"61","author":"J Sieper","year":"2002","unstructured":"Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002;61:iii8\u201318.","journal-title":"Ann Rheum Dis"},{"key":"570_CR47","first-page":"966","volume":"26","author":"J Ruof","year":"1999","unstructured":"Ruof J, Stucki G. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol. 1999;26:966\u201370.","journal-title":"J Rheumatol"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-023-00570-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-023-00570-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-023-00570-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T18:44:52Z","timestamp":1688669092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-023-00570-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,23]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["570"],"URL":"https:\/\/doi.org\/10.1007\/s40744-023-00570-0","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,23]]},"assertion":[{"value":"8 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}